About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat ...

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an ...

Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) ...

Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) ...

Reduction of catecholamine synthesis by as much as 70% has been achieved in man with the oral administration of a-methyl-para-Ltyrosine, a tyrosine hydroxylase inhibitor. Significant reduction of ...

The corelease suggests that exocytosis is the mechanism of catecholamine secretion. To investigate whether physiologic catecholamine secretion is exocytotic in humans, we measured plasma ...

ConspectusIn the rapidly evolving landscape of regenerative medicine, the field of bone tissue engineering stands as a beacon of innovative progress, pushing the boundaries of what is achievable in ...